XML 29 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net Loss $ (7,592,961) $ (10,524,330)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 12,026 200,766
Stock-based compensation 3,283,913 5,191,214
Net loss (gain) from investments (78,510) 157,590
Loss on extinguishment of debt & accounts payable 264,261
Amortization of debt discount 864,454 840,311
Right-of-use asset (2,591) 3,324
Income tax benefit 666,616
Net cash used in operating activities (3,168,858) (3,032,629)
Accounts receivable and notes receivable (46,046) (128,238)
Inventory (6,979)
Deposits & prepaid expenses (29,853) (16,081)
Accounts payable 342,078 104,176
Accrued liabilities 85,611 207,762
Cash Flows from Investing Activities:    
Cash acquired in business combination 9,000
Sales of marketable securities 936,330 2,203,666
Purchase of marketable securities (713,622) (1,403,666)
Acquisition of fixed assets (35,431) (29,384)
Net cash provided by investing activities 187,277 779,616
Cash Flows from Financing Activities:    
Sale of common stock 925,000 750,000
Redemption of common stock (136,827)
Proceeds from convertible notes payable 1,935,000
Proceeds from notes payable, related party 1,649,800
(Payments) proceeds from PPP loan (3,723) (3,686)
Payments on line of credit (3,318) (8,263)
Net cash provided by financing activities 2,430,932 2,673,051
(Decrease) increase in Cash (550,649) 420,038
Cash at beginning of period 751,017 260,838
Cash at end of period 200,368 680,876
Supplemental Cash Flow Information    
Cash paid for interest 200,700 99,000
Cash paid for income taxes 2,025 0
Non-cash investing and financing activities:    
Common stock issued for business combination $ 0 $ 0